Defining a correlate of protection for chikungunya virus vaccines

Keyphrases

• Chikungunya Infection 50%
• Chikungunya Vaccine 50%
• Chikungunya Virus (CHIKV) 100%
• Chikungunya Virus Infection 50%
• Clinical Benefit 50%
• Clinical Efficacy 50%
• Clinical Potential 50%
• Clinical Testing 50%
• Clinical Trials 50%
• Correlates of Protection 100%
• Efficacy Trial 50%
• Febrile Illness 50%
• Licensure 50%
• Long-term Sequelae 50%
• Nonclinical Testing 50%
• Pathway-based Approach 50%
• Potential Challenges 50%
• Surrogates of Protection 50%
• Testing Challenges 50%
• Vaccine Antigen 50%
• Virus Vaccine 100%

Medicine and Dentistry

• Chikungunya 100%
• Chikungunya Virus 100%
• Clinical Trial 33%
• Disease 33%
• Sequela 33%
• Virus Vaccine 100%

Pharmacology, Toxicology and Pharmaceutical Science

• Chikungunya 100%
• Chikungunya Virus 100%
• Clinical Trial 33%
• Disease 33%
• Virus Vaccine 100%